The Children's Hospital of Colorado

Aurora, CO

Sorting 2 by

Accepting patients

Larotrectinib

A Pilot and Surgical Study of Larotrectinib for Treatment of Children With Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Learn more
  • Tyrosine Kinase (TK) Inhibitor
  • Phase 1

Accepting patients

CARE Study

A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
Learn more
  • Tyrosine Kinase (TK) Inhibitor
  • Phase 1/2
  • Has results